Skip to main content

Month: April 2021

Intema Signs Letter of Intent to Acquire Advertiise Technologies Inc.

Advertiise acquisition to complement Intema’s eFlyerMaker and HypeX.gg marketing services with a leading global online advertising marketplace. Acquisition to be accretive to Intema’s revenues: Advertiise has over 25,000 users from 40 countries, over 150,000 global advertising listings, and over 135 million daily advertising impressions. Advertiise ranked #1 in Google SEO for 3 years in a row and was selected as a finalist in 2016 in StartUp Canada, and one of the Top10 Canadian Startups in 2017. Current size of the advertising industry worldwide is US$600 billion and continues to grow 4-6% annually.1MONTREAL, April 14, 2021 (GLOBE NEWSWIRE) — Intema Solutions Inc. (“Intema” or the “Corporation”) (TSXV: ITM, OTCMKTS: ITMZF) is pleased to announce that it has entered into a letter of intent on April 13, 2021 to acquire all of...

Continue reading

Intema signe une lettre d’entente pour acquérir Advertiise Technologies Inc.

L’acquisition d’Advertiise permet de renforcer les services de marketing d’eFlyerMaker et de HypeX.gg, grâce à une place de marché publicitaire mondiale en ligne de premier plan. L’acquisition contribuera aux revenus d’Intema : Advertiise compte plus de 25 000 utilisateurs dans 40 pays, plus de 150 000 annonces publicitaires mondiales et plus de 135 millions d’impressions publicitaires quotidiennes. Advertiise s’est classée au premier rang du référencement Google pendant 3 années consécutives et a été sélectionnée comme finaliste en 2016 dans StartUp Canada, et fut parmi l’une des Top10 Canadian Startups en 2017. La taille actuelle du secteur mondial de la publicité est de 600 G$ US et continue de croître de 4 à 6 % par an.1MONTRÉAL, 14 avr. 2021 (GLOBE NEWSWIRE) — Intema Solutions Inc....

Continue reading

Saniona to Present Preclinical Data on SAN903 at the ASPET Annual Meeting at Experimental Biology 2021

PRESS RELEASE April 14, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on rare diseases, today announced that its research team will present preclinical data on SAN903 in a model of idiopathic pulmonary fibrosis at the American Society of Pharmacology and Experimental Therapeutics (ASPET) Annual Meeting at Experimental Biology (EB) 2021, which is being held virtually between April 27 and 30, 2021. SAN903 is a novel, potential first-in-class medicine based on inhibition of the calcium-activated potassium ion channel, KCa3.1. This ion channel is found in immune cells and fibroblasts, and it controls the proliferation, migration and release of cytokines and collagen. Previous studies have indicated that KCa3.1 inhibition may reduce inflammation and fibrosis in various diseases. Saniona is currently evaluating...

Continue reading

Saniona presenterar prekliniska resultat för SAN903 på ASPETs årsmöte för experimentell biologi 2021

PRESSMEDDELANDE 14 april 2021 Saniona (OMX: SANION), ett biofarmaceutiskt företag med klinisk utveckling fokuserad på sällsynta sjukdomar, meddelar idag att bolagets vetenskapliga team kommer att presentera prekliniska resultat för SAN903 i en modell av idiopatisk lungfibros vid American Society of Pharmacology and Experimental Therapeutics (ASPET) årsmöte för experimentell biologi (EB) 2021, som kommer att hållas digitalt 27–30 april 2021. SAN903 är en ny first-in-class-hämmare av den kalciumaktiverade kaliumjonkanalen KCa3.1. Jonkanalen återfinns i immunceller och fibroblaster där den reglerar spridningen, migrationen och frisättandet av cytokiner och kollagen. Tidigare studier har indikerat att hämning av KCa3.1 kan minska inflammation och fibros i samband med olika sjukdomar. Saniona utvärderar för närvarande SAN903 i prekliniska...

Continue reading

Open-Source Power Delivery Software Enables Code Integration for USB System Differentiation

CHANDLER, Ariz., April 14, 2021 (GLOBE NEWSWIRE) — USB Type-C with Power Delivery (PD) and open-source software are two technologies leading the next wave of wired connectivity. With Microchip Technology Inc.’s (Nasdaq: MCHP) new Power Delivery Software Framework (PSF), designers can now modify and own the IP in their USB-C PD systems. By merging their proprietary code with Microchip’s fully functionable PD stack, designers have the ultimate flexibility for creating differentiated product offerings while choosing from a wide variety of Microchip SmartHubs, microcontrollers (MCUs) and standalone PD solutions for their USB systems. Microchip’s PSF solution offers both an open-source code base for power delivery and a comprehensive programming environment, removing the need for manufacturer dependence and making it easy for users to...

Continue reading

Predictmedix Announces a 2 Year Revenue Contract With Flow Alkaline Spring Water for North American Operations

TORONTO, April 14, 2021 (GLOBE NEWSWIRE) — Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) (“Predictmedix” or the “Company”) is pleased to announce a 24 month, multi-unit contract to deploy Safe Entry Stations throughout the North American operations of Flow Water Inc. (“Flow Alkaline Spring Water” or “Flow”). The partnership marks the successful completion of our initial pilot, as the technology is now scaled and deployed across all of Flow’s operations both in Canada and the USA. A pioneer in the health and wellness arena, Flow was one of the first in Eastern Canada to partner with Predictmedix and Juiceworks Exhibits (JUICEWORKS) to implement Safe Entry Stations at their Aurora facilities in August 2020. North America’s first socially responsible artisan alkaline water plant, Flow continues its spirit of innovation...

Continue reading

BIO-key’s Cloud-Based PortalGuard® Identity-as-a-Service (IDaaS) Platform Expands Footprint to Over 55 California Community Colleges with Addition of Mendocino College

WALL, N.J., April 14, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced the company’s footprint in providing security solutions for higher education continues to grow within the California Community College System with more than fifty-five colleges now under support. Most recently, Mendocino College has selected BIO-key’s PortalGuard IDaaS solution to enhance its online user experience, secure critical enterprise application access, and reduce IT resource-related expenses. PortalGuard IDaaS will significantly improve user access by providing secure single sign-on to applications, including O365, G-Suite, Canvas, and Ellucian, among others, while replacing Shibboleth IdP, which can be challenging to manage...

Continue reading

Lowell Farms and Ascend Wellness Holdings Announce Strategic Licensing Agreement, Bringing Award-Winning Lowell Smokes to Illinois and Massachusetts

Lowell Smokes award-winning pre-rolls available this summer in two of the top four largest cannabis markets outside of the West Coast SALINAS, Calif. and CHICAGO, April 14, 2021 (GLOBE NEWSWIRE) — Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-based vertically-integrated cannabis company with advanced production capabilities including cultivation, extraction, manufacturing, brand sales, marketing and distribution, and multi-state, vertically-integrated cannabis operator Ascend Wellness Holdings, LLC (“AWH”) are bringing Lowell Farms’ iconic Lowell Smokes brand to AWH retail locations in Massachusetts and Illinois via a strategic licensing agreement. The collaboration will allow AWH, a distinguished pre-roll producer in Illinois, to produce Lowell Smokes – one of California’s leading pre-roll products – for sale at...

Continue reading

Inovalon Announces First Quarter 2021 Earnings Conference Call

BOWIE, Md., April 14, 2021 (GLOBE NEWSWIRE) — Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced that it will hold a conference call for investors on Wednesday, April 28, 2021, at 5:00 p.m. Eastern Time. During the conference call, management will review highlights from the Company’s first quarter 2021 financial results, which will be announced via press release after the close of market trading. The conference call can be accessed by dialing (855) 783-2604, conference ID 3581518; international callers should dial (631) 485-4882 using the same ID. The call will be available for replay on Inovalon’s website at www.inovalon.com. About Inovalon Inovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform,...

Continue reading

LexaGene Hosts a Seminar to Present MiQLab Data from Veterinary Samples

MiQLab is sensitive enough to detect the vast majority of clinical infections caused by target organisms ~100% positive percent agreement with culture data on processed canine urine samples ~99% negative percent agreement with culture data on processed canine urine samples ~99% overall percent agreement with culture data on processed canine urine samples Detected Staphylococcus in 21 of 23 (91%) specimens from skin infections in a correlation study Detected the mecA gene in 8 of 9 (89%) specimens that contained methicillin resistant Staphylococcus Quantitative data on par with culture (r2 ~0.95)BEVERLY, Mass., April 14, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to host a...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.